The Influence of the Proinflammatory Cytokine, Osteopontin, on Autoimmune Demyelinating Disease

Multiple sclerosis is a demyelinating disease, characterized by inflammation in the brain and spinal cord, possibly due to autoimmunity. Large-scale sequencing of cDNA libraries, derived from plaques dissected from brains of patients with multiple sclerosis (MS), indicated an abundance of transcripts for osteopontin (OPN). Microarray analysis of spinal cords from rats paralyzed by experimental autoimmune encephalomyelitis (EAE), a model of MS, also revealed increased OPN transcripts. Osteopontin-deficient mice were resistant to progressive EAE and had frequent remissions, and myelin-reactive T cells in OPN–/– mice produced more interleukin 10 and less interferon-γ than in OPN+/+ mice. Osteopontin thus appears to regulate T helper cell–1 (TH1)–mediated demyelinating disease, and it may offer a potential target in blocking development of progressive MS.

[1]  D. Heinegård,et al.  Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[2]  K. Mohler,et al.  Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. , 1992, Journal of immunology.

[3]  D. Denhardt,et al.  Osteopontin: a protein with diverse functions , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  J. Gimble,et al.  Osteoblastic gene expression during adipogenesis in hematopoietic supporting murine bone marrow stromal cells , 1993, Journal of cellular physiology.

[5]  L. Steinman,et al.  Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. , 1994, The Journal of clinical investigation.

[6]  D. Laskin,et al.  Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells. , 1994, The Journal of biological chemistry.

[7]  C. Polman,et al.  The small heat-shock protein αB-crystallin as candidate autoantigen in multiple sclerosis , 1995, Nature.

[8]  M. Chen,et al.  Vitronectin and Integrin Vitronectin Receptor Localization in Multiple Sclerosis Lesions , 1995, Journal of neuropathology and experimental neurology.

[9]  J. Haines,et al.  A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex , 1996, Nature Genetics.

[10]  P. Goodfellow,et al.  A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22 , 1996, Nature Genetics.

[11]  D. Hinds,et al.  A full genome search in multiple sclerosis , 1996, Nature Genetics.

[12]  L Steinman,et al.  Multiple Sclerosis: A Coordinated Immunological Attack against Myelin in the Central Nervous System , 1996, Cell.

[13]  K. Becker,et al.  Analysis of a sequenced cDNA library from multiple sclerosis lesions , 1997, Journal of Neuroimmunology.

[14]  N. Baumann,et al.  Expression of TNFα in central neurons of Lewis rat spinal cord after EAE induction , 1997 .

[15]  D. Mitchell,et al.  Short peptide-based tolerogens without self-antigenic or pathogenic activity reverse autoimmune disease. , 1998, Journal of immunology.

[16]  Piero Carninci,et al.  Characterization of gene expression in mouse blastocyst using single-pass sequencing of 3995 clones. , 1998, Genomics.

[17]  C. Bernard,et al.  Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein. , 1998, Autoimmunity.

[18]  M. McKee,et al.  Mice Lacking Osteopontin Show Normal Development and Bone Structure but Display Altered Osteoclast Formation In Vitro , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  S. Rittling,et al.  Detection of mouse osteopontin by western blotting. , 1998, Biochemical and biophysical research communications.

[20]  R. Rudick,et al.  Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.

[21]  H. Garren,et al.  Suppressive immunization with DNA encoding a self-peptide prevents autoimmune disease: modulation of T cell costimulation. , 1999, Journal of immunology.

[22]  D. Denhardt,et al.  Osteopontin Function in Pathology: Lessons from Osteopontin-Deficient Mice , 1999, Nephron Experimental Nephrology.

[23]  I. Weissman,et al.  Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Cha,et al.  Expression of osteopontin mRNA in the adult rat brain , 1999, Neuroscience Letters.

[25]  M. Glimcher,et al.  Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. , 2000, Science.

[26]  D. Pitt,et al.  Glutamate excitotoxicity in a model of multiple sclerosis , 2000, Nature Medicine.

[27]  R. Pedotti,et al.  An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide , 2001, Nature Immunology.

[28]  Lawrence Steinman,et al.  Multiple sclerosis: a two-stage disease , 2001, Nature Immunology.

[29]  D. Torchia,et al.  Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin. , 2001, Biochemical and biophysical research communications.